# HS2 30 Pharmaceutical... trade corridors | Yugalinks

> Published by **Yugalinks**, global trade intelligence for growing businesses.

Explore reported Pharmaceutical products trade corridors at HS2 30: leading routes, trade value, three-year growth, HS6 coverage, distance, and FTA context.

Canonical: https://www.yugalinks.com/trade/sector/hs2/30/corridors

## Page details

- Page type: HS2 sector top trade corridors
- Sector: **HS2 30 - Pharmaceutical products**
- Coverage: 1,995-2,024
- Publisher: [Yugalinks](https://www.yugalinks.com/)
- LinkedIn: [Follow Yugalinks](https://in.linkedin.com/company/yugalinks)

## Sector snapshot

| Measure | Value |
| --- | ---: |
| Latest reported sector trade | $900.6B |
| Corridors shown | 25 |
| Active HS6 products | 43 |
| Top five corridor share | 14.3% |
| Reported trend | Growing |

## Explore this sector

- [Read the HS2 sector overview](https://www.yugalinks.com/trade/sector/hs2/30)
- [Open the Pharmaceutical products workspace](https://www.yugalinks.com/app?hs=3000)
- [Check data coverage](https://www.yugalinks.com/data-coverage)
- [Read the methodology](https://www.yugalinks.com/methodology)
- [Review data sources](https://www.yugalinks.com/data-sources)

## Leading route

The leading reported corridor is **Ireland -> USA, Puerto Rico and US Virgin Islands**, with $41.6B in the latest reported year, +8.7% three-year growth, 4.6% market share, 33 active HS6 products, 5,129 km, and not reported FTA context.

## Corridor ranking

| Rank | Route | Latest trade | 3-year growth | Market share | HS6 products | Distance | FTA context |
| ---: | --- | ---: | ---: | ---: | ---: | ---: | --- |
| 1 | Ireland -> USA, Puerto Rico and US Virgin Islands | $41.6B | +8.7% | 4.6% | 33 | 5,129 km | Not reported |
| 2 | Switzerland, Liechtenstein -> USA, Puerto Rico and US Virgin Islands | $28.4B | +1.3% | 3.2% | 31 | 6,339 km | Not reported |
| 3 | Germany -> USA, Puerto Rico and US Virgin Islands | $23.8B | +2.7% | 2.6% | 35 | 6,402 km | Not reported |
| 4 | Slovenia -> Switzerland, Liechtenstein | $20.4B | +82.9% | 2.3% | 19 | 481 km | Reported |
| 5 | Belgium -> USA, Puerto Rico and US Virgin Islands | $14.9B | +11.8% | 1.7% | 35 | 5,904 km | Not reported |
| 6 | Italy -> USA, Puerto Rico and US Virgin Islands | $12.4B | +29.8% | 1.4% | 36 | 6,907 km | Not reported |
| 7 | Singapore -> USA, Puerto Rico and US Virgin Islands | $11.6B | +36.4% | 1.3% | 26 | 15,347 km | Reported |
| 8 | Switzerland, Liechtenstein -> Germany | $11.5B | -0.4% | 1.3% | 37 | 674 km | Reported |
| 9 | USA, Puerto Rico and US Virgin Islands -> Germany | $11.2B | +10.3% | 1.2% | 35 | 6,402 km | Not reported |
| 10 | India -> USA, Puerto Rico and US Virgin Islands | $10.7B | +10.8% | 1.2% | 37 | 11,771 km | Not reported |
| 11 | Ireland -> Belgium | $10.4B | -6.9% | 1.2% | 28 | 776 km | Reported |
| 12 | Germany -> Switzerland, Liechtenstein | $10.2B | +0.4% | 1.1% | 39 | 674 km | Reported |
| 13 | Ireland -> Netherlands | $10.2B | +53% | 1.1% | 36 | 757 km | Reported |
| 14 | Italy -> Switzerland, Liechtenstein | $9.1B | +39.7% | 1% | 30 | 684 km | Reported |
| 15 | Canada -> USA, Puerto Rico and US Virgin Islands | $8.3B | +8.6% | 0.9% | 37 | 556 km | Reported |
| 16 | Germany -> Netherlands | $8.0B | +1% | 0.9% | 37 | 579 km | Reported |
| 17 | Ireland -> Germany | $8.0B | +0.1% | 0.9% | 30 | 1,321 km | Reported |
| 18 | Switzerland, Liechtenstein -> Slovenia | $7.9B | +20.8% | 0.9% | 27 | 481 km | Reported |
| 19 | USA, Puerto Rico and US Virgin Islands -> Japan | $7.8B | +3.6% | 0.9% | 31 | 10,872 km | Not reported |
| 20 | United Kingdom -> USA, Puerto Rico and US Virgin Islands | $7.5B | +10.3% | 0.8% | 38 | 5,585 km | Not reported |
| 21 | Italy -> Belgium | $7.3B | +0.8% | 0.8% | 30 | 1,174 km | Reported |
| 22 | USA, Puerto Rico and US Virgin Islands -> China | $6.6B | +1.4% | 0.7% | 35 | 11,883 km | Not reported |
| 23 | Netherlands -> Germany | $6.5B | -7.4% | 0.7% | 37 | 579 km | Reported |
| 24 | China -> USA, Puerto Rico and US Virgin Islands | $6.3B | +25.3% | 0.7% | 34 | 11,883 km | Not reported |
| 25 | USA, Puerto Rico and US Virgin Islands -> Canada | $6.2B | -6.5% | 0.7% | 40 | 556 km | Reported |

## Growth leaders

- **Slovenia -> Switzerland, Liechtenstein**: +82.9% three-year growth, $20.4B latest value, 2.3% market share, and 481 km.
- **Ireland -> Netherlands**: +53% three-year growth, $10.2B latest value, 1.1% market share, and 757 km.
- **Italy -> Switzerland, Liechtenstein**: +39.7% three-year growth, $9.1B latest value, 1% market share, and 684 km.
- **Singapore -> USA, Puerto Rico and US Virgin Islands**: +36.4% three-year growth, $11.6B latest value, 1.3% market share, and 15,347 km.
- **Italy -> USA, Puerto Rico and US Virgin Islands**: +29.8% three-year growth, $12.4B latest value, 1.4% market share, and 6,907 km.

## Access comparison

| Route context | Latest trade | Corridors | Average 3-year growth |
| --- | ---: | ---: | ---: |
| FTA reported | $135.4B | 14 | +15.9% |
| FTA not reported | $171.3B | 11 | +10.5% |

## Call to action

[Open the Pharmaceutical products workspace](https://www.yugalinks.com/app?hs=3000) - compare the sector across countries, products, and routes in the Yugalinks workspace.

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-28). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.